186 related articles for article (PubMed ID: 37310446)
41. The role of activation of the 5-HT1A receptor and adenylate cyclase in the antidepressant-like effect of YL-0919, a dual 5-HT1A agonist and selective serotonin reuptake inhibitor.
Qin JJ; Chen HX; Zhao N; Yuan L; Zhang YZ; Yang RF; Zhang LM; Li YF
Neurosci Lett; 2014 Oct; 582():104-8. PubMed ID: 25220701
[TBL] [Abstract][Full Text] [Related]
42. Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression.
du Jardin KG; Liebenberg N; Müller HK; Elfving B; Sanchez C; Wegener G
Psychopharmacology (Berl); 2016 Jul; 233(14):2813-25. PubMed ID: 27236785
[TBL] [Abstract][Full Text] [Related]
43. Ketamine supresses REM sleep and markedly increases EEG gamma oscillations in the Wistar Kyoto rat model of treatment-resistant depression.
Kantor S; Lanigan M; Giggins L; Lione L; Magomedova L; de Lannoy I; Upton N; Duxon M
Behav Brain Res; 2023 Jul; 449():114473. PubMed ID: 37146722
[TBL] [Abstract][Full Text] [Related]
44. NLX-112, a highly selective 5-HT
Newman-Tancredi A; Depoortère R; Carilla-Durand E; Tarayre JP; Kleven M; Koek W; Bardin L; Varney MA
Pharmacol Biochem Behav; 2018 Feb; 165():56-62. PubMed ID: 29126856
[TBL] [Abstract][Full Text] [Related]
45. Ketamine and its metabolite, (2R,6R)-HNK, restore hippocampal LTP and long-term spatial memory in the Wistar-Kyoto rat model of depression.
Aleksandrova LR; Wang YT; Phillips AG
Mol Brain; 2020 Jun; 13(1):92. PubMed ID: 32546197
[TBL] [Abstract][Full Text] [Related]
46. Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action.
Lucas G; Rymar VV; Du J; Mnie-Filali O; Bisgaard C; Manta S; Lambas-Senas L; Wiborg O; Haddjeri N; Piñeyro G; Sadikot AF; Debonnel G
Neuron; 2007 Sep; 55(5):712-25. PubMed ID: 17785179
[TBL] [Abstract][Full Text] [Related]
47. Short- and long-term antidepressant effects of ketamine in a rat chronic unpredictable stress model.
Jiang Y; Wang Y; Sun X; Lian B; Sun H; Wang G; Du Z; Li Q; Sun L
Brain Behav; 2017 Aug; 7(8):e00749. PubMed ID: 28828210
[TBL] [Abstract][Full Text] [Related]
48. Molecular Signaling Mechanisms for the Antidepressant Effects of NLX-101, a Selective Cortical 5-HT
Cabanu S; Pilar-Cuéllar F; Zubakina P; Florensa-Zanuy E; Senserrich J; Newman-Tancredi A; Adell A
Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337135
[TBL] [Abstract][Full Text] [Related]
49. Long-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of mice.
Ma XC; Dang YH; Jia M; Ma R; Wang F; Wu J; Gao CG; Hashimoto K
PLoS One; 2013; 8(2):e56053. PubMed ID: 23390559
[TBL] [Abstract][Full Text] [Related]
50. Role of Serotonin and Noradrenaline in the Rapid Antidepressant Action of Ketamine.
López-Gil X; Jiménez-Sánchez L; Campa L; Castro E; Frago C; Adell A
ACS Chem Neurosci; 2019 Jul; 10(7):3318-3326. PubMed ID: 31244055
[TBL] [Abstract][Full Text] [Related]
51. Improvement of urethral dysfunction by 5-HT
Li M; Chen X; Cao N; Lv R; Gu B
Neurourol Urodyn; 2022 Sep; 41(7):1528-1538. PubMed ID: 35870169
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of the anxiolytic-like effects of clomipramine in two rat strains with different anxiety vulnerability (Wistar and Wistar-Kyoto rats): participation of 5-HT1A receptors.
Rogel-Salazar G; López-Rubalcava C
Behav Pharmacol; 2011 Apr; 22(2):136-46. PubMed ID: 21301323
[TBL] [Abstract][Full Text] [Related]
53. Role of 5-HT1A Receptor Stimulation in the Medial Prefrontal Cortex in the Sustained Antidepressant Effects of Ketamine.
Fukumoto K; Iijima M; Funakoshi T; Chaki S
Int J Neuropsychopharmacol; 2018 Apr; 21(4):371-381. PubMed ID: 29309585
[TBL] [Abstract][Full Text] [Related]
54. Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naïve and "depressed" mice exposed to chronic mild stress.
Franceschelli A; Sens J; Herchick S; Thelen C; Pitychoutis PM
Neuroscience; 2015 Apr; 290():49-60. PubMed ID: 25595985
[TBL] [Abstract][Full Text] [Related]
55. Activation of prelimbic 5-HT1A receptors produces antidepressant-like effects in a unilateral rat model of Parkinson's disease.
Hui YP; Zhang QJ; Zhang L; Chen L; Guo Y; Qiao HF; Wang Y; Liu J
Neuroscience; 2014 May; 268():265-75. PubMed ID: 24680938
[TBL] [Abstract][Full Text] [Related]
56. Multimodal imaging study of the 5-HT
Chaib S; Vidal B; Bouillot C; Depoortere R; Newman-Tancredi A; Zimmer L; Levigoureux E
Neuroimage Clin; 2023; 39():103497. PubMed ID: 37632990
[TBL] [Abstract][Full Text] [Related]
57. Neurochemical and behavioural effects of hypidone hydrochloride (YL-0919): a novel combined selective 5-HT reuptake inhibitor and partial 5-HT
Zhang LM; Wang XY; Zhao N; Wang YL; Hu XX; Ran YH; Liu YQ; Zhang YZ; Yang RF; Li YF
Br J Pharmacol; 2017 May; 174(9):769-780. PubMed ID: 27882537
[TBL] [Abstract][Full Text] [Related]
58. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
Tordera RM; Monge A; Del Río J; Lasheras B
Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683
[TBL] [Abstract][Full Text] [Related]
59. Reactivity of 5-HT1A receptor in adult rats after neonatal noradrenergic neurons' lesion--implications for antidepressant-like action.
Dabrowska J; Nowak P; Brus R
Brain Res; 2008 Nov; 1239():66-76. PubMed ID: 18789911
[TBL] [Abstract][Full Text] [Related]
60. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
Engin E; Treit D; Dickson CT
Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
